Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Careful dosing and monitoring are crucial to prevent adrenal insufficiency when using ketoconazole for Cushing's disease.